UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In vitro and in vivo anti‐epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2‐related self‐limited epilepsy

British journal of pharmacology, 2022-01, Vol.179 (1), p.84-102

2022

Volltextzugriff (PDF)

Efficacy and safety of eslicarbazepine acetate versus controlled‐release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double‐blind, randomized, parallel‐group, multicenter study

Epilepsia (Copenhagen), 2018-02, Vol.59 (2), p.479-491

2018

Volltextzugriff (PDF)

Steady‐state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers

Epilepsia (Copenhagen), 2013-01, Vol.54 (1), p.108-116

2013

Volltextzugriff (PDF)

Efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: Integrated analysis of pooled data from double‐blind phase III clinical studies

Epilepsia (Copenhagen), 2013-01, Vol.54 (1), p.98-107

2013

Volltextzugriff (PDF)

Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate

Acta neurologica Scandinavica, 2020-05, Vol.141 (5), p.397-404

2020

Volltextzugriff (PDF)

Pharmacokinetics and drug interactions of eslicarbazepine acetate

Epilepsia (Copenhagen), 2012-06, Vol.53 (6), p.935-946

2012

Volltextzugriff (PDF)

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: A randomized, double‐blind, placebo‐controlled, parallel‐group phase III study

Epilepsia (Copenhagen), 2009-03, Vol.50 (3), p.454-463

2009

Volltextzugriff (PDF)

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III, double‐blind, randomized, placebo‐controlled trial

Epilepsia (Copenhagen), 2015-02, Vol.56 (2), p.244-253

2015

Volltextzugriff (PDF)

Eslicarbazepine Acetate: A Double‐blind, Add‐on, Placebo‐controlled Exploratory Trial in Adult Patients with Partial‐onset Seizures

Epilepsia (Copenhagen), 2007-03, Vol.48 (3), p.497-504

2007

Volltextzugriff (PDF)

Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers

Epilepsia (Copenhagen), 2013-08, Vol.54 (8), p.1453-1461

2013

Volltextzugriff (PDF)

Pooled efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: Data from four double‐blind placebo‐controlled pivotal phase III clinical studies

CNS neuroscience & therapeutics, 2017-12, Vol.23 (12), p.961-972

2017

Volltextzugriff (PDF)

Long‐term efficacy and safety of eslicarbazepine acetate: Results of a 1‐year open‐label extension study in partial‐onset seizures in adults with epilepsy

Epilepsia (Copenhagen), 2010-10, Vol.51 (10), p.1963-1969

2010

Volltextzugriff (PDF)

Single-Dose and Steady-State Pharmacokinetics of Eslicarbazepine Acetate (BIA 2-093) in Healthy Elderly and Young Subjects

Journal of clinical pharmacology, 2005-09, Vol.45 (9), p.1062-1066

2005

Volltextzugriff (PDF)

Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study

Clinical therapeutics, 2010, Vol.32 (1), p.179-192

2010

Volltextzugriff (PDF)

Pharmacokinetics, Efficacy, and Tolerability of Eslicarbazepine Acetate in Children and Adolescents With Epilepsy

Journal of clinical pharmacology, 2008-08, Vol.48 (8), p.966-977

2008

Volltextzugriff (PDF)

Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (≥60 years) and younger (18–59 years) adults

Epilepsy research, 2021-01, Vol.169, p.106478-106478, Article 106478

2021

Volltextzugriff (PDF)

Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker

Biopharmaceutics & drug disposition, 2007-07, Vol.28 (5), p.249-256

2007

Volltextzugriff (PDF)

Eslicarbazepine Acetate (BIA 2-093)

Neurotherapeutics, 2007, Vol.4 (1), p.88-96

2007

Volltextzugriff (PDF)

Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs

Epilepsy research, 2018-03, Vol.141, p.83-89

2018

Volltextzugriff (PDF)

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & behavior, 2020-04, Vol.105, p.106962-106962, Article 106962

2020

Volltextzugriff (PDF)

Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus

BMC neuroscience, 2014-12, Vol.15 (1), p.134-134, Article 134

2014

Volltextzugriff (PDF)

Disposition of eslicarbazepine acetate in the mouse after oral administration

Fundamental & clinical pharmacology, 2008-10, Vol.22 (5), p.529-536

2008

Volltextzugriff (PDF)

Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma

Analytical and bioanalytical chemistry, 2010-06, Vol.397 (4), p.1605-1615

2010

Volltextzugriff (PDF)

Effect of repeated administration of eslicarbazepine acetate on the pharmacokinetics of simvastatin in healthy subjects

Epilepsy research, 2013-09, Vol.106 (1), p.244-249

2013

Volltextzugriff (PDF)

Eslicarbazepine acetate exposure in pregnant women with epilepsy

Seizure (London, England), 2018-05, Vol.58, p.72-74

2018

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaEslicarbazepine Acetate

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(36)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Humans
(26)
Male
(24)
Neurosciences & Neurology
(23)
Clinical Neurology
(21)
Female
(21)
Adult
(20)
Epilepsy
(14)
Middle Aged
(14)
Adolescent
(12)
Antiepileptic Drugs
(12)
Dibenzazepines - Administration & Dosage
(12)
Dose-Response Relationship, Drug
(12)
Pharmacokinetics
(12)
Pharmacology & Pharmacy
(12)
Double-Blind Method
(11)
Young Adult
(11)
Anticonvulsants - Therapeutic Use
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In vitro and in vivo anti‐epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2‐related self‐limited epilepsy

Efficacy and safety of eslicarbazepine acetate versus controlled‐release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double‐blind, randomized, parallel‐group, multicenter study

Steady‐state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers

Efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: Integrated analysis of pooled data from double‐blind phase III clinical studies

Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate

Pharmacokinetics and drug interactions of eslicarbazepine acetate

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: A randomized, double‐blind, placebo‐controlled, parallel‐group phase III study

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III, double‐blind, randomized, placebo‐controlled trial

Eslicarbazepine Acetate: A Double‐blind, Add‐on, Placebo‐controlled Exploratory Trial in Adult Patients with Partial‐onset Seizures

Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers

Pooled efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: Data from four double‐blind placebo‐controlled pivotal phase III clinical studies

Long‐term efficacy and safety of eslicarbazepine acetate: Results of a 1‐year open‐label extension study in partial‐onset seizures in adults with epilepsy

Single-Dose and Steady-State Pharmacokinetics of Eslicarbazepine Acetate (BIA 2-093) in Healthy Elderly and Young Subjects

Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study

Pharmacokinetics, Efficacy, and Tolerability of Eslicarbazepine Acetate in Children and Adolescents With Epilepsy

Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (≥60 years) and younger (18–59 years) adults

Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker

Eslicarbazepine Acetate (BIA 2-093)

Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus

Disposition of eslicarbazepine acetate in the mouse after oral administration

Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma

Effect of repeated administration of eslicarbazepine acetate on the pharmacokinetics of simvastatin in healthy subjects

Eslicarbazepine acetate exposure in pregnant women with epilepsy

Aktive Filter

Suchergebnisse filtern